|
|
The high CD4/CD8 ratio and suppressed NK cell activity were improved by methyl-B12 treatment. The Japanese researchers headache state: We conclude that vitamin B12 acts as an immunomodulator for cellular immunity.11 B12 was used successfully in the treatment of IgE-mediated skin disorders. The German researchers conclude that therapy B12 (cobalamin) when applied to the skin one or more times per day exhibited ...excellent results in topical headache treatment of skin disorders and in particular of inflammatory and hyperproliferative skin therapy ailments and/or cutaneous manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact dermatitis, headache and other eczematous dermatitises...12 Click here for Allergy medication online. Jay M. Symptoms not very bad. Karl L. My congestion allergies did seem to get better after several days...Marsha R. I had some better days. Erin C. I believe it helped to a certain extent. therapy William R. Improved after 3 days. Nancy C. On day 16 I felt so much better, by day 30 allergies continued to be improved. Angel C. Background of Cyanocobalamin Treatment in Allergic Disease MECHANISM headache OF ACTION: Vitamin B12 is essential to cell growth therapy and cell division. B12 is the only known molecule in the human body uses with the element cobalt. The unique properties of cobalt permit a chemical reaction that produces the rungs of the DNA ladder. headache and therapy These rungs are called nucleotides. For any human cell to divide, it must copy its own DNA. For this replication to occur, new rungs of the ladder must be provided with the help of B12. In January 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin B12. In June 1997, the 62 placebo subjects were sent a questionnaire asking: How would you compare your overall allergy (hay fever) symptoms this spring to the last two springs? 20 people responded, with 15 reporting having had the B12 treatment, and 5 not. 12 of the 15 reported at least a slight improvement in overall allergy symptoms, and 1 of the 5. Improvement ratios - 12:3 having received treatment, 1:4 not having received treatment.8 A bioequivalence study showed headache that a 3000 mcg lozenge delivered therapy an headache equivalent amount of cyanocobalamin to the blood as a 15 mcg injection.9 From the spring to the summer patients with demonstrated allergic rhinitis received with the cyanocobalamin (or placebo) containing lozenge twice daily for 21 consecutive days. All subjects also received C and B oral multivitamins for 21 days. Twice daily subjects maintained therapy a nine-week diary on sneezing, runny nose, nasal congestion, itchy eyes, itchy nose and headache antihistamine (chlorpheniramine) use. In the post-treatment period, the active group (n=15) recorded on average a greater reduction in symptoms and in antihistamine use than the placebo therapy group (n=9). The results yielded reductions (0.1>p>0.01) headache in total weekly therapy symptom/rescue medication for the active group compared to the placebo for weeks headache 2, 6, 8 and 9. The results tend to replicate therapy those of the studies on injectable cyanocobalamin.10
|